Three Treatment of Chronic Obstructive Pulmonary Disease Patients
Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Forty five COPD patients will be recruited from Chest Disease Department, Tanta University
Hospital, Tanta, Egypt.
The aim of the study is to Compare between the effectiveness of three therapeutic options for
treatment of moderate and severe COPD patients .These therapeutic options include Inhaled
corticosteroid (ICS) plus long acting B2-agonist (LABA) combination, Inhaled corticosteroid
(ICS) plus long acting anticholinergic (LAAC) combination and Long acting B2-agonist (LABA)
plus long acting anticholinergic (LAAC) combination .
Phase:
Phase 4
Details
Lead Sponsor:
Tanta University
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate Tiotropium Bromide